Learning Objectives:

-Review characteristics of the most common hereditary kidney cancer syndromes.

-Discuss surgical management of hereditary kidney cancer syndromes.

-Outline the use of belzutifan in patients with von Hippel-Lindau disease.

Session date: 
12/18/2024 - 7:00am to 8:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Mark Ball, MD